A001065 Stock Overview

Manufactures and sells medicines and medical supplies in Japan and internationally. More details

A001065 fundamental analysis
Snowflake Score
Valuation	5/6
Future Growth	3/6
Past Performance	6/6
Financial Health	6/6
Dividends	3/6

Rewards

Trading at 74.2% below our estimate of its fair value

Earnings are forecast to grow 14.55% per year

Earnings grew by 178% over the past year

Trading at good value compared to peers and industry

Risk Analysis

Shareholders have been diluted in the past year

My Notes

Capture your thoughts, links and company narrative

JW Pharmaceutical Corporation Competitors

Huons Global

KOSDAQ:A084110

₩508.5b

DongKook Pharmaceutical

KOSDAQ:A086450

₩734.7b

Boryung

KOSE:A003850

₩687.6b

Dong-A Socio Holdings

KOSE:A000640

₩672.6b

Price History & Performance

Summary of share price highs, lows and changes for JW Pharmaceutical
Historical stock prices
Current Share Price	₩29,650.00
52 Week High	₩33,333.33
52 Week Low	₩25,050.00
Beta	0.53
1 Month Change	2.24%
3 Month Change	-1.66%
1 Year Change	-9.32%
3 Year Change	-7.00%
5 Year Change	19.30%
Change since IPO	488.30%

Recent updates

Shareholder Returns

	A001065	KR Pharmaceuticals	KR Market
7D	0.9%	1.8%	-2.1%
1Y	-9.3%	4.3%	-9.0%

Return vs Industry: A001065 underperformed the KR Pharmaceuticals industry which returned 4.3% over the past year.

Return vs Market: A001065 matched the KR Market which returned -9% over the past year.

Price Volatility

Is A001065's price volatile compared to industry and market?
A001065 volatility
A001065 Average Weekly Movement	5.4%
Pharmaceuticals Industry Average Movement	5.6%
Market Average Movement	6.6%
10% most volatile stocks in KR Market	12.7%
10% least volatile stocks in KR Market	3.3%

Stable Share Price: A001065 has not had significant price volatility in the past 3 months compared to the KR market.

Volatility Over Time: A001065's weekly volatility (5%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1945	n/a	Young-Sub Shin	www.jw-pharma.co.kr

JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases , and pancreatic cancer. The company also offers infant care system, gynecological examining table, operating room equipment, steam sterilizer, and other equipment.

JW Pharmaceutical Corporation Fundamentals Summary

How do JW Pharmaceutical's earnings and revenue compare to its market cap?
A001065 fundamental statistics
Market cap	₩593.61b
Earnings (TTM)	₩69.72b
Revenue (TTM)	₩736.54b

8.4x

P/E Ratio

0.8x

P/S Ratio

Is A001065 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A001065 income statement (TTM)
Revenue	₩736.54b
Cost of Revenue	₩401.81b
Gross Profit	₩334.74b
Other Expenses	₩265.01b
Earnings	₩69.72b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	2.83k
Gross Margin	45.45%
Net Profit Margin	9.47%
Debt/Equity Ratio	35.9%

How did A001065 perform over the long term?

See historical performance and comparison

Dividends

1.7%

Current Dividend Yield

32%

Payout Ratio

Does A001065 pay a reliable dividends?

See A001065 dividend history and benchmarks

When do you need to buy A001065 by to receive an upcoming dividend?
JW Pharmaceutical dividend dates
Ex Dividend Date	Dec 27 2024
Dividend Pay Date	Apr 25 2025
Days until Ex dividend	2 days
Days until Dividend pay date	121 days

Does A001065 pay a reliable dividends?

See A001065 dividend history and benchmarks

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/24 18:08
End of Day Share Price	2024/12/24 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

JW Pharmaceutical Corporation is covered by 8 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Jisoo Lee	DAOL Investment & Securities Co., Ltd.
Myung Sun Lee	DB Financial Investment Co. Ltd.
Hyung Soo Kim	Hanwha Investment & Securities Co., Ltd.

JW Pharmaceutical KOSE:A001065 Stock Report